Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
about
TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cellsMACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.ATP citrate lyase mediates resistance of colorectal cancer cells to SN38.Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.Quantitative proteomics analysis reveals glutamine deprivation activates fatty acid β-oxidation pathway in HepG2 cells.Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancerPhotodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In VivoNAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patientsTumor glycolysis as a target for cancer therapy: progress and prospects.An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma.Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy.Warburg effect regulated by amphiregulin in the development of colorectal cancer.MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism.Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen Treatment Related to the Warburg Effect in Hepatocarcinogenesis Producing GST-P-Expressing Proliferative Lesions.The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.Glycolysis inhibition improves photodynamic therapy response rates for equine sarcoids.HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer.Hypoxia and acidosis: immune suppressors and therapeutic targets.Suppressed de novo lipogenesis by plasma membrane citrate transporter inhibitor promotes apoptosis in HepG2 cells.miR-133a function in the pathogenesis of dedifferentiated liposarcoma.Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis
P2860
Q28119089-A116DA09-565A-4248-B9B5-E51B9DB04971Q33673940-1A994E11-C0FA-4D20-9AF1-F980BF1132D8Q34996926-4D0E708C-8E0B-4227-BBD2-6F5ADDE41756Q35748982-29EFA663-0FDF-4A91-B201-4A48F9C65402Q35912447-A68C9287-34B6-4E7C-BAE8-CDF0FD32A03BQ36225499-FF4FFDB1-020B-4637-9064-2216E29E5183Q36729484-1AE22DFD-6A58-45FB-9760-37A795C8C7A1Q37087792-78EA9502-04C7-4BE8-96B1-E178CD057493Q37157355-A2F2E49E-0667-47CD-932D-9E3D7DE0B127Q37208788-E8A8FEEE-6310-4FB4-BD7E-2E23803FF2DDQ38168262-DB29255D-F66E-4B95-833B-72C9CF054EBCQ38850429-D45CABA5-069A-446C-B239-A4EF58079017Q38980187-DBB4F4D7-EFD4-4D02-83D9-D359828F48DFQ39125005-DFA8A392-189A-4E20-AE53-D8F038B41EE8Q39760741-A6DAFECA-2E48-4FBA-B5E8-C0086DCF6D84Q41208796-97E654A7-D1D7-491A-8EDC-F76FEE74C523Q41431419-A5707293-ABD2-40DB-9465-D4B3D45C673AQ41493386-FBE16833-818C-44E6-8B0F-D609C8EC00F9Q47774336-4D77AFC2-02F0-4CED-AABD-11D6C5572FD5Q48146067-243F6B53-C858-484A-BDBB-C36DBBAAEECFQ48305205-A86A655A-C74A-4C40-80E5-B24E7A92069DQ49795867-FFB2FD02-6132-46D7-B946-E75725B2713CQ52683574-151A9B1E-4187-43B4-B9E8-E943202654F6Q55418143-9448D8D8-6A08-4489-AA1C-1DCDC83AC761Q55443461-85D7CE27-EC31-4659-B5C8-18A7662DA7D6Q58615775-C447B1EA-F53B-4010-A350-ECEB3F1B94A6
P2860
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@ast
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@en
type
label
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@ast
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@en
prefLabel
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@ast
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@en
P2860
P356
P1476
Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
@en
P2093
Jin-Ming Yang
P2860
P356
10.4161/CBT.22958
P577
2012-11-28T00:00:00Z